To align with the national drive to expand the footprint of Singapore as a biopharma hub
A centre of excellence for groundbreaking research in Proteins, Cells, and Nucleic Acids bioprocessing technologies
Cultivating partnerships with industry to advance innovations and translate research into industrial applications
Providing development and training programmes to support biomanufacturing and research activities in Singapore
A*STAR Bioprocessing Technology Institute (BTI) focuses on advancing bioprocessing technologies and research over its 35-year history. Our current vision is to Realise Quality Processes for Biomanufacturing, with a strong emphasis on Proteins, Cells, and Nucleic Acids.
To achieve BTI’s vision of ensuring Quality Processes for Biomanufacturing, the institute develops innovative research capabilities and advanced biomanufacturing technologies. Modality-specific strategies are key to BTI achieving its mission of developing Singapore's biomanufacturing sector where asset classes are in various stages of maturity and development.
BTI’s core capabilities are systematically organised around its four principal divisions, which oversee 19 Enabling Research Groups, and Technology Platforms and Consortia. The matrix structure of BTI’s divisions enables the swift and flexible assembly of research teams with synergistic capabilities, allowing them to effectively address research and industry problem statements.
.jpg)
.jpg)
.png)
